#PCSK9 gene editing therapy for lowering LDL-C: New frontier in CV pharmacotherapy? academic.oup.com/ehjcvp/advance… #EHJPharmacotherapy 💊 Stefan Agewall Basil Lewis #Cardiology #CardioTwitter

Disparities in the diagnosis & management of PAD exist by sex, race, socioeconomic status & geography, and eliminating these inequities will require improvements in education, access to care & health policy. Read a #JACC Scientific Statement to learn more: bit.ly/3Rthy8M

Some trust in chariots, and some in horses, but we will remember the name of the Lord our God. Our trust in him will never be disappointed. That is why we have come this far. Able God, daalu.

Not all ARBs are created equal #Nephpearls 👉🏼 pubmed.ncbi.nlm.nih.gov/17563549/

Her name is Modele Ogunniyi and she is a model to these young and future cardiologists! 😁🔥🔥 Modele Ogunniyi, MD, MPH #FutureOfCardiology #ACC24 #CardiologyNeedsUs

A fantastic day at the #ACC24! Lots of learning, interaction and innovation. Excited to have met incredible minds and to dive into various aspects of cardiology. Looking forward to more insightful sessions and presentations. American College of Cardiology Englewood Hospital Internal Medicine Residency Modele Ogunniyi, MD, MPH

Thankful for the amazing experience at #ACC24! Grateful to have presented a case and humbled by the invaluable connections made with mentors and friends. American College of Cardiology Englewood Hospital Internal Medicine Residency

#ACC2024 #TopClinicalTrials #Summary #AtOneGlanceForYou ! 😍Terrific amount of advancement in Cardiovascular science that made us think, that made us learn and that made us evolve. ❤️🙏 American College of Cardiology #ACCFIT #LoveForHeart 💡⭐️🫀🫶👏

Our ‘Live Well Series’ continues and this week featured Gabriel and Todd (PGY1s) leading the conversation on ‘Knowing your Numbers’ at the Shirvan Live Well Center. They fielded questions on preventive care for non-communicable diseases (NCDs). 👏🏽🩺 #PrimaryCare #MedTwitter

Terrific work presented at #SCAI2024 by Chidubem Ezenna MD & Oghenetejiri Gbegbaje, MD. from Baystate Health! Meta-analysis showing intracoronary imaging improves #PCI outcomes in #SIHD but not #ACS. Congratulations!

SUMMIT trial results presented at #AHA24 show tirzepatide reduced the risk of worsening #heartfailure events & improved #QoL in patients w/ #HFpEF & obesity. “Cardiologists now have an ever-expanding armamentarium to treat HFpEF,” says Dr. Christopher Kramer MD. bit.ly/4hSxZ9J

Empowering the community with knowledge about #CVD! 🫀 Grateful for the opportunity to promote heart health with the best team! A successful event as part of NJ Chapter of ACC #HeartHealth #NJACCCelebratesDiversity #HeartMonth Marian VanDyck-Acquah MD FASNC FASE FACC ambica_nair Gabriel Alugba, MD Vlad ☁️

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: Circulation JACC Journals 🥸Here are class 1 recommendations from the document; Massive effort - congratulations to the authors: Sunil V. Rao 😱 Below 👇👇👇

One of the most important trials at American College of Cardiology #ACC25 ! Compared fluid restriction to liberal approach in #HeartFailure. Why? This affects individuals w/HF EVERY DAY! ✨No benefit of Fluid Restriction ✨No HARM for liberal fluid intake ✨Improved QOL in liberal fluid intake

It’s an honor to be surrounded by brilliant minds. Grateful for the opportunity to dive into the science of cardiology, connect with like-minded individuals, and absorb the latest innovations and knowledge. #ACC25 American College of Cardiology Association of Black Cardiologists Renée Bullock-Palmer MD FACC FAHA FASNC FASE FSCCT

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity: NEJM 🥸 SURMOUNT-5 Trial: Wow! 😱 Summary 👇👇👇

Reevaluating Beta-Blocker Recommendations Post-Myocardial Infarction: Perspective on the 2025 Guideline Update: JACC Journals 🥸Commentary on the guidelines - early beta blocker use post MI - 😱Michael Nanna wrote extensively on this in older pts. 🥸Take a look 👇👇👇

🔴2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes:⤵️ A Report of ACC/AHA Joint Committee on Clinical Practice Guidelines #openaccess 🔹jacc.org/doi/10.1016/j.… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology

Sodium-Glucose Cotransporter 2 Inhibitor With and Without an Aldosterone Antagonist for Heart Failure With Preserved Ejection Fraction: The SOGALDI-PEF Trial: JACC Journals 🥸Nice work. 😱Summary 👇👇👇